Financial results - SPERANTA BIOXIM SRL

Financial Summary - Speranta Bioxim Srl
Unique identification code: 8639663
Registration number: J40/5975/1996
Nace: 8622
Sales - Ron
28.746
Net Profit - Ron
16.202
Employee
1
The most important financial indicators for the company Speranta Bioxim Srl - Unique Identification Number 8639663: sales in 2023 was 28.746 euro, registering a net profit of 16.202 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Speranta Bioxim Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 15.375 15.738 14.497 15.361 14.646 14.377 14.309 18.935 22.403 28.746
Total Income - EUR 15.375 15.854 14.499 15.361 14.646 14.563 14.309 18.935 22.403 28.746
Total Expenses - EUR 3.919 9.817 3.970 4.508 5.729 4.928 2.330 4.673 9.088 12.261
Gross Profit/Loss - EUR 11.456 6.037 10.530 10.853 8.917 9.635 11.979 14.262 13.315 16.484
Net Profit/Loss - EUR 10.995 5.562 10.095 10.392 8.478 9.198 11.589 13.695 12.911 16.202
Employees 1 1 1 1 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 28.7%, from 22.403 euro in the year 2022, to 28.746 euro in 2023. The Net Profit increased by 3.330 euro, from 12.911 euro in 2022, to 16.202 in the last year.

Check the financial reports for the company - Speranta Bioxim Srl

Rating financiar

Financial Rating -
Speranta Bioxim Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Speranta Bioxim Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Speranta Bioxim Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Speranta Bioxim Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Speranta Bioxim Srl - CUI 8639663

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 21.950 21.816 21.406 20.860 20.296 19.726 19.178 18.583 18.469 18.243
Current Assets 15.785 5.081 11.112 8.611 8.659 7.611 10.981 14.615 24.022 37.592
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 7.616 1.784 1.748 1.917 1.840 1.996 1.968 2.048 2.431 2.754
Cash 8.168 3.297 9.363 6.694 6.819 5.615 9.012 12.567 21.591 34.838
Shareholders Funds -98.452 -93.712 -82.662 -70.871 -61.093 -50.711 -38.161 -23.621 -10.783 5.452
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 136.187 120.858 115.179 100.341 90.048 78.048 68.319 56.818 53.274 50.574
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 37.592 euro in 2023 which includes Inventories of 0 euro, Receivables of 2.754 euro and cash availability of 34.838 euro.
The company's Equity was valued at 5.452 euro, while total Liabilities amounted to 50.574 euro. Equity increased by 16.202 euro, from -10.783 euro in 2022, to 5.452 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Speranta Bioxim Srl

Comments - Speranta Bioxim Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.